Cargando…

m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common and lethal digestive system cancers worldwide. N6-methyladenosine (m6A) modification plays an essential role in diverse critical biological processes and may participate in the development and progression of HCC. METHODS: We downlo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Yan, Jiang, Guichun, Xie, Yanmin, Li, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629938/ https://www.ncbi.nlm.nih.gov/pubmed/36339682 http://dx.doi.org/10.1155/2022/2427987

Ejemplares similares

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

The m(6)A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma
por: Ma, Ensi, et al.
Publicado: (2023)

TMEM106C contributes to the malignant characteristics and poor prognosis of hepatocellular carcinoma
por: Duan, Jicheng, et al.
Publicado: (2021)

Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma
por: Qin, Jian, et al.
Publicado: (2018)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
por: Zhu, Yuezhi, et al.
Publicado: (2023)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

ROCK2 Polymorphism and Expression Contribute to Increased Susceptibility and Poor Prognosis in Hepatocellular Carcinoma
por: Qin, Lifeng, et al.
Publicado: (2022)

Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2022)

Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Upregulator of Cell Proliferation Predicts Poor Prognosis in Hepatocellular Carcinoma and Contributes to Hepatocarcinogenesis by Downregulating FOXO3a
por: Xie, Chan, et al.
Publicado: (2012)

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma
por: Zhong, Cheng‐Qian, et al.
Publicado: (2018)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis
por: Guo, Jiang, et al.
Publicado: (2022)

FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
por: Wang, Yan, et al.
Publicado: (2020)

CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2019)

CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis
por: Gu, Xuefeng, et al.
Publicado: (2019)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
por: Zhao, Gang, et al.
Publicado: (2013)

Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma
por: Liu, Jian, et al.
Publicado: (2016)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Upregulated TUBG1 expression is correlated with poor prognosis in hepatocellular carcinoma
por: Zhang, Kainan, et al.
Publicado: (2022)

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2021)

The Cancer Genome Atlas (TCGA) based m(6)A methylation-related genes predict prognosis in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2020)

Identification of m6A-Related lncRNA to Predict the Prognosis of Patients with Hepatocellular Carcinoma
por: Yang, Hao, et al.
Publicado: (2022)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jiang, Jie, et al.
Publicado: (2021)

Analysis of the role of m6A and lncRNAs in prognosis and immunotherapy of hepatocellular carcinoma
por: Xu, Yan, et al.
Publicado: (2022)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma
por: Liu, Xincheng, et al.
Publicado: (2017)

Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma
por: Zhao, Jing, et al.
Publicado: (2019)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Lee, Boin, et al.
Publicado: (2014)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma
por: Liu, Ting, et al.
Publicado: (2023)

CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016)

Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis
por: Huang, Yan, et al.
Publicado: (2012)

The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma
por: Chen, Ying, et al.
Publicado: (2021)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
por: Zuo, Shan-Ru, et al.
Publicado: (2018)

The Combination of Periostin Overexpression and Microvascular Invasion Is Related to a Poor Prognosis for Hepatocellular Carcinoma
por: Jang, Se Young, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_534t6jhsf8dcfmgo4trrdgb2b3